BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20842634)

  • 1. His-tag binding by antibody C706 mimics β-amyloid recognition.
    Teplyakov A; Obmolova G; Canziani G; Zhao Y; Gutshall L; Jung SS; Gilliland GL
    J Mol Recognit; 2011; 24(4):570-5. PubMed ID: 20842634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A coiled conformation of amyloid-β recognized by antibody C706.
    Teplyakov A; Obmolova G; Gilliland GL
    Alzheimers Res Ther; 2017 Aug; 9(1):66. PubMed ID: 28830506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β.
    Bohrmann B; Baumann K; Benz J; Gerber F; Huber W; Knoflach F; Messer J; Oroszlan K; Rauchenberger R; Richter WF; Rothe C; Urban M; Bardroff M; Winter M; Nordstedt C; Loetscher H
    J Alzheimers Dis; 2012; 28(1):49-69. PubMed ID: 21955818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural studies of the tethered N-terminus of the Alzheimer's disease amyloid-β peptide.
    Nisbet RM; Nuttall SD; Robert R; Caine JM; Dolezal O; Hattarki M; Pearce LA; Davydova N; Masters CL; Varghese JN; Streltsov VA
    Proteins; 2013 Oct; 81(10):1748-58. PubMed ID: 23609990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-beta-anti-amyloid-beta complex structure reveals an extended conformation in the immunodominant B-cell epitope.
    Miles LA; Wun KS; Crespi GA; Fodero-Tavoletti MT; Galatis D; Bagley CJ; Beyreuther K; Masters CL; Cappai R; McKinstry WJ; Barnham KJ; Parker MW
    J Mol Biol; 2008 Mar; 377(1):181-92. PubMed ID: 18237744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallization and preliminary X-ray diffraction analysis of the Fab fragment of WO2, an antibody specific for the Abeta peptides associated with Alzheimer's disease.
    Wun KS; Miles LA; Crespi GA; Wycherley K; Ascher DB; Barnham KJ; Cappai R; Beyreuther K; Masters CL; Parker MW; McKinstry WJ
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 May; 64(Pt 5):438-41. PubMed ID: 18453721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An anti-Aβ (amyloid β) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing Aβ oligomers from the amyloid pathway.
    Marín-Argany M; Rivera-Hernández G; Martí J; Villegas S
    Biochem J; 2011 Jul; 437(1):25-34. PubMed ID: 21501114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
    Matharu B; El-Agnaf O; Razvi A; Austen BM
    Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, solution conformation, and antibody recognition of oligotuftsin-based conjugates containing a beta-amyloid(4-10) plaque-specific epitope.
    Manea M; Hudecz F; Przybylski M; Mezõ G
    Bioconjug Chem; 2005; 16(4):921-8. PubMed ID: 16029033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the anti-His tag antibody 3D5 single-chain fragment complexed to its antigen.
    Kaufmann M; Lindner P; Honegger A; Blank K; Tschopp M; Capitani G; Plückthun A; Grütter MG
    J Mol Biol; 2002 Apr; 318(1):135-47. PubMed ID: 12054774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation.
    Di Scala C; Chahinian H; Yahi N; Garmy N; Fantini J
    Biochemistry; 2014 Jul; 53(28):4489-502. PubMed ID: 25000142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
    Geylis V; Steinitz M
    Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.
    Bard F; Barbour R; Cannon C; Carretto R; Fox M; Games D; Guido T; Hoenow K; Hu K; Johnson-Wood K; Khan K; Kholodenko D; Lee C; Lee M; Motter R; Nguyen M; Reed A; Schenk D; Tang P; Vasquez N; Seubert P; Yednock T
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2023-8. PubMed ID: 12566568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the Cu+ binding in the 1-16 region of the amyloid-β peptide involved in Alzheimer's disease.
    Furlan S; Hureau C; Faller P; La Penna G
    J Phys Chem B; 2010 Nov; 114(46):15119-33. PubMed ID: 21038888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid fibril recognition with the conformational B10 antibody fragment depends on electrostatic interactions.
    Haupt C; Morgado I; Kumar ST; Parthier C; Bereza M; Hortschansky P; Stubbs MT; Horn U; Fändrich M
    J Mol Biol; 2011 Jan; 405(2):341-8. PubMed ID: 21059358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc binding agonist effect on the recognition of the beta-amyloid (4-10) epitope by anti-beta-amyloid antibodies.
    Zirah S; Stefanescu R; Manea M; Tian X; Cecal R; Kozin SA; Debey P; Rebuffat S; Przybylski M
    Biochem Biophys Res Commun; 2004 Aug; 321(2):324-8. PubMed ID: 15358179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monoclonal antibodies against amyloid-beta from healthy adults.
    Geylis V; Kourilov V; Meiner Z; Nennesmo I; Bogdanovic N; Steinitz M
    Neurobiol Aging; 2005 May; 26(5):597-606. PubMed ID: 15708434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomization of amyloid-β-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity.
    Saraiva AM; Cardoso I; Saraiva MJ; Tauer K; Pereira MC; Coelho MA; Möhwald H; Brezesinski G
    Macromol Biosci; 2010 Oct; 10(10):1152-63. PubMed ID: 20480510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.